"New advances of Diabetes Conversations with Best practices around the world"
Speaker: Barbara Eichorst, MS, RD, CDE
Diabetes Conversations features Conversation Map™ tools created and designed by Healthy Interactions Inc., in collaboration with the International Diabetes Federation, sponsored by Eli Lilly and Company.
"Current and future trials shaping the landscape of diabetes treatment"
Chairperson and contributor: Associate Professor Marg McGill
Speaker: Professor Rury Holman
This breakfast session will provide a global perspective of both current and future diabetes trials. Presenter, Professor Rury Holman is involved in multiple trials currently assessing different agents and different aspects of diabetes management. Professor Holman's presentation will provide a comprehensive understanding of the clinical evidence to come and attendees will have an opportunity to ask many important questions surrounding the management of type 2 diabetes now and into the future.
"Diabetes and pregnancy – Latest updates"
Speakers: Prof. David McIntyre, Ms Alison Barry, and Mrs Amanda Bartlett
Pregnancies complicated by diabetes are at an increased risk of adverse foetal and maternal outcomes and longer-term health problems in offspring. Based on the long experience with their use, the current insulin gold standards in pregnancy include short-acting insulin and neutral protamine hagedorn (NPH). Given that evidence for long-acting insulin analogues in pregnancy has been lacking, the outcomes of the multinational, non-inferiority, randomised trial of insulin detemir versus NPH is timely. Insulin detemir was not inferior to NPH and was as well tolerated with regards to perinatal outcomes. These data support the Category A listing of insulin detemir, with implications for diabetes management before and during pregnancy.
Gestational diabetes mellitus (GDM) is associated with short and long term risks to mother and infant. Yet, there is considerable controversy as to how to diagnose GDM and provide optimal management during and after pregnancy. The Australasian Diabetes in Pregnancy Society (ADIPS) originally formulated recommendations for the testing and diagnosis of gestational diabetes mellitus (GDM) in 1991. In May 2013, ADIPS elected to revise these guidelines. This session will discuss the current GDM diagnostic criteria, and provide practical guidance for the management and follow up of GDM in general practice.
"Use of evidence in clinical practice: should we apply treatment guidelines or clinical judgement?"
Chairperson: Richard Morecroft
Prof Ele Ferrannini, University of Pisa, Italy
A/Prof Sophia Zoungas, Monash University, VIC
W/Prof Tim Davis, University of Western Australia, WA
Dr Gary Deed, Mediwell, QLD
Come join us for a stimulating panel discussion, hosted by Richard Morecroft, on how individualisation of treatment works in practice in Australia and Europe, and what this means for the health outcomes of patients with Type 2 Diabetes Mellitus. Hear interactive discussion of how the panel of Ele Ferrannini, Tim Davis, Sophia Zoungas and Gary Deed see individualisation of care evolving in their respective parts of the health system, and how they approach individualisation in their practice. Discussion will no doubt be informed by the ADA/EASD 2012 position statement, the Australian guidelines for the treatment of type 2 diabetes, and explore the challenges in aligning evidence-based best-practice with health delivery and reimbursement considerations in Europe and Australia. Listen to discussion of both the European and Australian experience with the SGLT2 inhibitor class and where the panel see them fitting into their clinical practice.
Includes presentation of next years award.
*GP CME Eligible Session*
08.30 – 08:40 Introduction
Dr Jennifer Conn
08:40 –0 9:10 Understanding the consumer perspective Ms Renza Scibilia
Ms Jennifer Coburn
9:10 – 9:40 Consulting skills for supporting self-management Dr Christel Hendrieckx Dr Alison Nankervis
Dr Jennifer Conn
9:40 – 10:10 Consulting skills for optimising mental health
Dr Carol Silberberg
10:10 – 10:30 Panel discussion Dr Jennifer Conn Ms Renza Scibilia Ms Jennifer Coburn Dr Christel Hendrieckx Dr Alison Nankervis Dr Carol Silberberg
*GP CME Eligible Session*
Only ADS Members are able to attend the Annual General Meeting